NXUR

Nxu, Inc.

OTC · Truck & Bus Bodies · Inc. DE · CIK 0001722969
$0.001950 0.00%
Vol
Inst. Holders4 funds
Inst. Value$67.4K
Inst. Activity0 buys / 2 sells
Exchange OTC·Sector Truck & Bus Bodies·Inc. DE·CIK 0001722969·Prev Close $0.001950

Recent Activity

Inst.
VANGUARD GROUP INC — EXIT
0 shares ($0.00)
Inst.
UBS Group AG — EXIT
0 shares ($0.00)

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$52.3KEXIT
UBS Group AG$13.5KEXIT
MORGAN STANLEY$1.6K
BANK OF AMERICA CORP$24.00
4 institutional holders with $67.4K total value (25,261 shares) as of 2025-Q1. Top holders: VANGUARD, UBS, MORGAN. Net buying activity: 2 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q1

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC19,585$52.3K77.5%EXIT -100.0%
2UBS Group AG5,058$13.5K20.0%EXIT -100.0%
3MORGAN STANLEY609$1.6K2.4%
4BANK OF AMERICA CORP /DE/9$24.000.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
VANGUARD GROUP INCEXIT19,5850-100.0%$0.002025-Q2
UBS Group AGEXIT5,0580-100.0%$0.002025-Q2
VANGUARD GROUP INCNEW19,585$52.3K2025-Q1
UBS Group AGNEW5,058$13.5K2025-Q1

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2025-03-31
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2025-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.